Immunotherapy for SARS-CoV-2: potential opportunities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunotherapy for SARS-CoV-2: potential opportunities

Published:2020-08-12 Issue:10 Volume:20 Page:1111-1116
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Pashaei Mehrnoosh¹,Rezaei Nima¹²³

Affiliation:

1. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

2. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran

3. Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran

Funder

not funded

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2020.1807933

Reference40 articles.

1. COVID-19: Developing from an Outbreak to A Pandemic

2. Adherence of the General Public to Self-Protection Guidelines During the COVID-19 Pandemic

3. Coronavirus Disease 2019 (COVID-19): A Perspective from China

4. The Molecular Biology of SARS Coronavirus

5. SARS‐CoV‐2: A comprehensive review from pathogenicity of the virus to clinical consequences

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Integrated SARS-CoV-2 Genome Presence in PBMC, Oropharyngeal, and Nasopharyngeal Samples of COVID-19 Patients;Jundishapur Journal of Microbiology;2024-04-20

2. A human monoclonal antibody neutralizes SARS-CoV-2 Omicron variants by targeting the upstream region of spike protein HR2 motif;hLife;2024-03

3. Mental Healthcare in Pediatrics During the COVID-19 Pandemic: A Call for International Public Health Action;Advances in Experimental Medicine and Biology;2024

4. Clinical Trials of Mesenchymal Stem Cells for the Treatment of COVID 19;Current Stem Cell Research & Therapy;2023-10-05

5. Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we?;Cell Communication and Signaling;2023-09-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3